Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Updated Results from the Phase 1/2 ACE-CL-001 Study
Blood (2017)
  • John C. Byrd, Ohio State University
  • William G Wierda, University of Texas MD Anderson Cancer Center
  • Anna Schuh, University of Oxford
  • Stephen Devereux, King's College
  • Jorge M. Chaves
  • Jennifer R. Brown, Harvard University
  • Peter Hillmen, St James's University Hospital
  • Peter Martin, NewYork–Presbyterian Hospital
  • Farrukh T. Awan, Ohio State University
  • Deborah M. Stephens, Huntsman Cancer Institute
  • Paolo Ghia, Vita-Salute San Raffaele University
  • Jacqueline C. Barrientos, Hofstra University
  • John M. Pagel, Cancer Institute
  • Jennifer A. Woyach, Ohio State University
  • Prista Charuworn
  • Ahmed Hamdy, Hamad Medical Corporation
  • Raquel Izumi
  • Priti Patel, Onyx Pharmaceuticals
  • Wayne M. Rothbaum
  • Min Hui Wang
  • Richard R. Furman, NewYork–Presbyterian Hospital
Link
Disciplines
Publication Date
December 7, 2017
Citation Information
John C. Byrd, William G Wierda, Anna Schuh, Stephen Devereux, et al.. "Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Updated Results from the Phase 1/2 ACE-CL-001 Study" Blood Vol. 130 (2017) p. 498 - 498
Available at: http://works.bepress.com/john-pagel/8/